BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
4.440
+0.020 (0.45%)
At close: Jul 31, 2025, 4:00 PM
4.400
-0.040 (-0.90%)
After-hours: Jul 31, 2025, 4:00 PM EDT
ANSYS Market Cap
BioAge Labs has a market cap or net worth of $159.17 million as of July 31, 2025.
Market Cap
159.17M
Enterprise Value
-166.49M
1-Year Change
n/a
Ranking
Category
Stock Price
$4.44
Market Cap Chart
Since the IPO on September 26, 2024, BioAge Labs's market cap has decreased from $615.01M to $159.17M, a decrease of -74.12%. That is a compound annual growth rate of -79.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2025 | 158.46M | -23.66% |
| Dec 31, 2024 | 207.56M | -66.25% |
| Sep 26, 2024 | 615.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.35B |
| Johnson & Johnson | 402.82B |
| AbbVie | 334.40B |
| UnitedHealth Group | 241.34B |
| AstraZeneca | 236.88B |
| Novartis AG | 227.02B |
| Abbott Laboratories | 223.66B |
| Novo Nordisk | 221.96B |